Latest evaluation and validation of cancer drugs and their targets has demonstrated the lack and inadequate development of new and better drugs, based on available protocols. Even though the specificity of drug targets is a great challenge in the pharmaco-proteomics field of cancer biology, for eradicating such hurdles and paving the way for the drugs of future, a novel step has been envisaged here to study the relation between drug target network and the corresponding drug network using the advanced concepts of proteomics and network biology. The literature mining was done for the collection of receptors and the ligands. About 1000 natural compounds were collected and out of those 300 molecules showed anti-cancer activity against colon cancer. Ligand Vs multiple receptor docking was done using the software Quantum 3.3.0; the results were further used for the designing of a well connected Protein Ligand Interaction(PLI) network of colon cancer. The obtained network is then extrapolated to sort out the receptors expressed in the specific cancer type. The network is then statistically analyzed and represented by the graphical interpretation, in order to ascertain the hub nodes and their locally parsed neighbours. Based on the best docking scores, the graphs obtained from the docking analysis are statistically validated with the help of VisANT. In the network three hub nodes Neutrophil cytosol factor 2, UV excision repair protein RAD23 homolog A, & Receptor-type tyrosine-protein phosphatase eta were identified, which showed the highest interaction with the ligands. Butyrate and Farnesol showed highest interaction as ligands. Multiple Sequence Alignment was done of the binding site sequence of the drug targets to find out the evolutionary closeness of the binding sites. The phylogenetic tree was also constructed to further validate the observation. Further in-vitro and in-vivo studies needs to be done to analyse the receptor specificity and anti tumor activity of these compounds in Colon cancer.
Introduction to Study
Treatment of diseases and the application of scientific approach in the field of computer aided drug discovery and designing has become much more pronounced with the increased occurrences of genetic diseases in the recent past. Hence there is a lot of work that needs to be done in the field of in-silico drug designing in order to get rid of such new diseases using Network Pharmacology. The two methods by which a drug does its role is by either stimulating the target activity(agonist) or by down regulating its activity(antagonist) [1] . In this paper we have discussed an Oncogenic proteins that participate in signal transduction pathways play a pivotal role in the transmission of a signal from the extracellular environment, through the cell membrane, into the cytoplasm and to the nucleus where transcription is initiated and even modulated to generate proteins that will eventually contribute to the cancerous phenotype. The function of these proteins is vital for homeostasis in the cells and tissues, moreover they control processes such as cell division, differentiation and apoptosis. All these molecules are potential targets for anti cancer drug designing due to the very fact that inhibition or activation of their function will lead to the elimination of the tumor cells. Issues related to these compounds, such as mechanism-based toxicity and development of resistance, have to be addressed in order to ensure their successful development as chemo preventive agents. The continuation of the research in the development of these compounds as drugs for the future cancer will pave the way for adoption of novel strategies [5] , [6] .
Treatment of cancer involves a very high degree of complications and unseen factors like the possible side-effects, hence making successful treatment of cancer all the more difficult. Most cancers are highly invasive and there are problems of recurrence even after surgery, chemotherapy and radiation treatment. Butyrate is found to play a protective role in colon cancer by inhibiting the enzymes up regulated in colon cancer and responsible for the classic erroneous growth [7] .The iso-prenoid alcohol Farnesol is an effective inducer of cell cycle arrest and apoptosis in a variety of carcinoma cell types. In addition, Farnesol has been found to function as a chemo preventative and anti-tumor agent in colon cancer [8] .
Gene expression is the result of post transcriptional & translational modification of gene products. Therefore the upregulated genes (highly expressed) in Colon cancer are sorted out for the further validation by experimentation and analysis by Hyper Geometric Test. The result obtained is fed into a well defined network, demonstrating the relationship between the various involved elements in order to ascertain their biological properties and functions. The centralities of the biological entities define their importance and biological hierarchy in the devised network. 
Materials and Methods

A. Data mining, Target & Lead Identification:
The first step involved was the collection of Protein Drug Targets. From the PDB database, the disease proteins were collected in order to study the Colon cancer. The Colon cancer specific natural Signal Transduction Modulators were annotated from a wide range of publishers and databases like Wiley, Blackwell Synergy, Medline, Pubchem, Ingenta Connect, Chemfinder, Drug Bank, etc. The protein structures were collected from various online databases. The structures of the compounds i.e. the ligands were also collected from various sources.
Collection of Drug Targets
The colon cancer related proteins, extracted and validated leading to the 3 drug targets were considered based on their association with the specific cancer and the significance level of the protein in the disease as well as its involvement with the cellular processes, biological functions and molecular functions were assessed. In Table 1 The Ligand-Drug Target In order to study the effects of colon cancer specific signal transduction modulators on the biological network of colon cancer, ligand Vs multi receptor docking was performed to elucidate the high grade specificity of the ligands for best fit. The analysis has been done on the basis of their docking score and RMS value. After the protein and ligand docking, the scores matrix was created from the scores obtained. Therefore a Structural Biology approach has been used for the classification and interpretation of the Systems Biology Network Model. 
B. Statistical Analysis:
The two sets (X, Y) of ligands and the target receptors respectively are taken, using their mean docking score & by help of the tool, VisANT [9] the highest degree of interaction was found to be with Neutrophil cytosol factor 2, UV excision repair protein RAD23 homolog A, Receptor-type tyrosine-protein phosphatase eta genes, where they shared degree distribution and it was found to be average score of 3.938 and the correlation coefficient was found to be 0.95, the graph was plotted for this statistical analysis data. Node degree is represented by its visible interactions. The distribution is calculated to see their fitness with power-law curve. 
C. Sequence and Evolutionary Analysis:
The identification of a good binding site and characterization of a drug target protein is of prime importance that leads it into its functional annotations. Therefore multiple sequence alignment is done to measure the evolutionary conservation of the binding sites of drug proteins that hold much evidence for the best fit of a ligand. The conserved binding site proved to be functionally enriched. The sequence analysis of the binding site was done for the Signal transduction Drug Target ProteinsNeutrophil cytosol factor 2, UV excision repair protein RAD23 homolog A and Receptor-type tyrosine-protein phosphatase eta. The sequence analysis score shows a high degree of evolutionary conservation among the binding site sequences of the drug target proteins. The phylogenetic profile of the proteins depicts low substitution rate & less gap penalty which indicates that they belong to same protein family. The evolutionary tree was drawn using CLUSTALW2 [11] . A rooted Phylogenetic tree with a unique node corresponding to the most recent common ancestor was found using the evolutionary analysis study. 
D. Matrix Analysis
The scoring matrix was plotted using the scores obtained from multiple receptor docking to identify the possible drug targets and were found to be Neutrophil cytosol factor 2, UV 
Results-
Thus, out of 300 natural molecules two molecules were selected for final study namely 
Conclusion-
The interpretation of colon cancer network gives 3 hub nodes. The most prominent interactions were observed with Neutrophil cytosol factor 2, UV excision repair protein 
